Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
29/02/202007:59Dow Jones NewsAmid Steep Declines in Stocks, Investors Seek Winners in Health CareNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/02/202008:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
27/02/202010:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/02/202008:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/02/202008:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/02/202004:06Dow Jones NewsRegeneron Up Nearly 6%, Best Performer in the Nasdaq 100 So Far Today -- Data TalkNASDAQ:REGNRegeneron Pharmaceuticals Inc
15/02/202009:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/02/202008:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/02/202008:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/02/202022:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/02/202008:01PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/02/202003:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/02/202008:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/02/202009:00PR Newswire (US)EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with ...NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/02/202003:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/02/202001:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/02/202001:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/02/202023:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/02/202023:13Dow Jones NewsRegeneron Pharmaceuticals Posts Higher Revenue in 4QNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/02/202022:30PR Newswire (US)Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/02/202001:00PR Newswire (US)Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New CoronavirusNASDAQ:REGNRegeneron Pharmaceuticals Inc
29/01/202009:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
28/01/202022:30Dow Jones NewsRegeneron, Sanofi Get FDA Priority Review of Dupixent in Children With Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/01/202016:59PR Newswire (US)FDA Accepts for Priority Review Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermati...NASDAQ:REGNRegeneron Pharmaceuticals Inc
28/01/202008:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
23/01/202004:01PR Newswire (US)Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/01/202001:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
10/01/202023:00PR Newswire (US)Regeneron to Report Fourth Quarter and Full Year 2019 Financial and Operating Results and Host Conference Call and Webcast on...NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/01/202023:00PR Newswire (US)Regeneron Announces Encouraging Garetosmab Phase 2 Results in Patients with Ultra-Rare Debilitating Bone DiseaseNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/01/202006:02PR Newswire (US)Publication Highlights Regeneron's Costimulatory Bispecific Antibodies, an Emerging Class of Cancer ImmunotherapyNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN